Amanta Healthcare Share Price: What Could the Next 3 Years Look Like?

The Amanta Healthcare share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 173, within a 52 week range of Rs 92 to Rs 192. This article lays out a scenario based Amanta Healthcare share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Amanta Healthcare Company Overview

Amanta Healthcare manufactures sterile liquid pharmaceutical products including IV fluids and injectables for domestic and export hospital and institutional markets. Understanding the business model is the first step in framing any credible Amanta Healthcare share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Amanta Healthcare
NSE Ticker	AMANTA
CMP	Rs 173
52 Week High	Rs 192
52 Week Low	Rs 92
Market Cap	Rs 671 Cr
Stock PE	40.8
Book Value	Rs 56.7
ROE	10.4%
ROCE	11.6%
Dividend Yield	0%

Where Does Amanta Healthcare Share Price Stand Today?

The stock currently trades about 10 percent below its 52 week high of Rs 192, which means the market has already tempered some of its optimism. For anyone building a Amanta Healthcare share price forecast, this correction matters for the Amanta Healthcare share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Amanta Healthcare commands a market capitalisation of Rs 671 Cr and trades at a price to earnings multiple of 40.8. The company generates a return on equity of 10.4% and a return on capital employed of 11.6%, which places it in the category of businesses with moderate return ratios. These numbers anchor the Amanta Healthcare share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Amanta Healthcare Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Amanta Healthcare share price forecast between now and 2030, and together they explain most of the dispersion in this Amanta Healthcare share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With moderate return ratios at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Amanta Healthcare share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Structural Tailwinds in Indian Pharmaceuticals

The Indian pharmaceutical market continues to grow in high single to low double digits, supported by chronic disease prevalence, better diagnosis rates and premiumisation of therapies. Companies with strong brand equity and field force productivity, like Amanta Healthcare, are positioned to grow ahead of the market. Sector trends are visible in the Nifty Pharma index, which serves as a useful barometer for the space.

Within the space, investors often benchmark Amanta Healthcare against peers such as Aarey Drugs & Pharmaceuticals, Alpa Laboratories and Anlon Healthcare on growth and valuations before forming a view on the Amanta Healthcare share price forecast.

Company Specific Catalysts

The bull case for Amanta Healthcare rests on rising hospital demand for sterile liquid formulations and export market expansion. If these play out on schedule, the Amanta Healthcare share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Amanta Healthcare share price forecast, while global risk aversion would do the opposite to the Amanta Healthcare share price outlook.

Amanta Healthcare Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Amanta Healthcare share price forecast using compounded annual growth assumptions applied to the current market price of Rs 173. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 185	Rs 200	Rs 215	4% to 16% CAGR on CMP
2028	Rs 190	Rs 220	Rs 250	4% to 16% CAGR on CMP
2030	Rs 205	Rs 265	Rs 335	4% to 16% CAGR on CMP

In the base case scenario of this Amanta Healthcare share price forecast, the 2030 level works out to roughly Rs 265, implying steady compounding from today’s levels. The bull case of Rs 335 assumes rising hospital demand for sterile liquid formulations and export market expansion delivers ahead of expectations, while the bear case of Rs 205 captures a scenario where growth stalls. That is an outcome band of about 18 percent to 94 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Amanta Healthcare Share Price

The Bull Case

The optimistic Amanta Healthcare share price forecast assumes rising hospital demand for sterile liquid formulations and export market expansion. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 335 by 2030.

The Bear Case

The cautious view centres on the fact that institutional and government tender pricing pressure and capacity utilisation are key risks. If these pressures dominate, the Amanta Healthcare share price forecast would skew toward the lower band and the stock could stagnate near Rs 205 even by 2030, underperforming broader indices.

Key Risks That Could Change the Amanta Healthcare Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Amanta Healthcare share price forecast.
• Valuation risk: At a PE of 40.8, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Institutional and government tender pricing pressure and capacity utilisation are key risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Amanta Healthcare Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Amanta Healthcare share price forecast lands in 2030 or what any single Amanta Healthcare share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising hospital demand for sterile liquid formulations and export market expansion gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Amanta Healthcare share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Amanta Healthcare share price live.

Conclusion

The Amanta Healthcare share price forecast for the next 3 years spans Rs 205 to Rs 335 by 2030 under the scenarios discussed, with a base case near Rs 265. Any credible Amanta Healthcare share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising hospital demand for sterile liquid formulations and export market expansion and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Amanta Healthcare share price forecast for the next 3 years?

Ans. The Amanta Healthcare share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 205 in the bear case to Rs 335 in the bull case, with a base case near Rs 265, depending on earnings delivery and market conditions.

What is the Amanta Healthcare share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 185 to Rs 215, with a base case around Rs 200. This assumes compounding on the current price of Rs 173 and is illustrative, not a guaranteed outcome.

What is the Amanta Healthcare share price forecast for 2028?

Ans. The 2028 scenario range is Rs 190 to Rs 250, with the base case near Rs 220. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Amanta Healthcare?

Ans. Amanta Healthcare currently trades at around Rs 173 on the NSE, within a 52 week range of Rs 92 to Rs 192. Prices change continuously during market hours, so check live quotes before acting.

Is Amanta Healthcare a good stock for the long term?

Ans. Amanta Healthcare has a credible long term story built on rising hospital demand for sterile liquid formulations and export market expansion, but it also carries risks since institutional and government tender pricing pressure and capacity utilisation are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Amanta Healthcare share price outlook for 2030?

Ans. The Amanta Healthcare share price outlook for 2030 spans Rs 205 to Rs 335 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Amanta Healthcare share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 40.8, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.